Training scientists to understand drug abuse biology
Official title: Postdoctoral Training in the Biology of Drug Abuse
Funded at University of Michigan at Ann Arbor · NIH-10846170 · Data updated 2026-11-12
This program is designed for new scientists and doctors who want to learn about how drugs affect the brain and behavior, helping them become experts in understanding and treating substance abuse.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $505,633 |
| NIH project number | 1T32DA060142-01 |
| Project ID | NIH-10846170 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are early-stage scientists and physicians interested in the biology of drug abuse.
✕Less likely to help
Patients currently undergoing treatment for substance abuse may not directly benefit from this training program.
What this research studies
This program offers postdoctoral training for early-stage scientists and physicians focused on the neurobiology of substance abuse. Participants will engage in a multidisciplinary environment at the University of Michigan, learning about the genetic, molecular, and behavioral aspects of drug addiction. The training includes hands-on research using advanced techniques to explore how drugs affect the brain and behavior, as well as developing essential skills for scientific communication and mentorship. This initiative aims to cultivate the next generation of experts in the field of drug abuse.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for substance abuse disorders.
How similar studies have gone: Previous training programs in similar fields have successfully produced advancements in understanding and treating substance abuse disorders.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Traynor, John R. — University of Michigan at Ann Arbor
- Study coordinator: Traynor, John R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.